A synthetic multifunctional mammalian pH sensor and CO2 transgene-control device

Molecular Cell

Volumn 55, Issue 3, 2014, Pages 397-408

  Ausländer, David ^a   Ausländer, Simon ^a   Charpin El Hamri, Ghislaine ^b   Sedlmayer, Ferdinand ^a   Müller, Marius ^a   Frey, Olivier ^a   Hierlemann, Andreas ^a   Stelling, Jörg ^a   Fussenegger, Martin ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BICARBONATE; CARBON DIOXIDE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; INSULIN; PROTON; TRANSCRIPTION FACTOR;

ADAPTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOREACTOR; CELL FUNCTION; CELL POPULATION; CELL VIABILITY; CHO CELL LINE; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DIFFUSION; DOWNSTREAM PROCESSING; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; HEK293 CELL LINE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESPONSE; MAMMAL CELL; MATHEMATICAL MODEL; MESENCHYMAL STEM CELL; MICROFLUIDICS; MOUSE; NONHUMAN; PH; PHYSIOLOGICAL PROCESS; PROMOTER REGION; SENSOR; SIGNAL TRANSDUCTION; SUSPENSION CELL CULTURE; SYNTHETIC BIOLOGY; TRANSCRIPTION REGULATION; TRANSGENE;

MAMMALIA; MUS;

ANIMALS; CARBON DIOXIDE; CELL LINE; CELL TRANSPLANTATION; CHO CELLS; CRICETULUS; DIABETIC KETOACIDOSIS; DISEASE MODELS, ANIMAL; FEMALE; HEK293 CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; MICE; MICROFLUIDIC ANALYTICAL TECHNIQUES; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; SYNTHETIC BIOLOGY;

EID: 84905569769     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2014.06.007     Document Type: Article

References (48)

1. Ausländer S., Ausländer D., Müller M., Wieland M., Fussenegger M. Programmable single-cell mammalian biocomputers. Nature 2012, 487:123-127.
2. Bacchus W., Lang M., El-Baba M.D., Weber W., Stelling J., Fussenegger M. Synthetic two-way communication between mammalian cells. Nat. Biotechnol. 2012, 30:991-996.
3. Barker J.M., Goehrig S.H., Barriga K., Hoffman M., Slover R., Eisenbarth G.S., Norris J.M., Klingensmith G.J., Rewers M. Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care 2004, 27:1399-1404. DAISY study.
4. Baumgärtel K., Genoux D., Welzl H., Tweedie-Cullen R.Y., Koshibu K., Livingstone-Zatchej M., Mamie C., Mansuy I.M. Control of the establishment of aversive memory by calcineurin and Zif268. Nat. Neurosci. 2008, 11:572-578.
5. Bouwens L., Houbracken I., Mfopou J.K. The use of stem cells for pancreatic regeneration in diabetes mellitus. Nat. Rev. Endocrinol. 2013, 9:598-606.
6. Casey J.R., Grinstein S., Orlowski J. Sensors and regulators of intracellular pH. Nat. Rev. Mol. Cell Biol. 2010, 11:50-61.
7. Chen Y.Y., Jensen M.C., Smolke C.D. Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems. Proc. Natl. Acad. Sci. USA 2010, 107:8531-8536.
8. Federiuk I.F., Casey H.M., Quinn M.J., Wood M.D., Ward W.K. Induction of type-1 diabetes mellitus in laboratory rats by use of alloxan: route of administration, pitfalls, and insulin treatment. Comp. Med. 2004, 54:252-257.
9. Gitzinger M., Kemmer C., El-Baba M.D., Weber W., Fussenegger M. Controlling transgene expression in subcutaneous implants using a skin lotion containing the apple metabolite phloretin. Proc. Natl. Acad. Sci. USA 2009, 106:10638-10643.
10. Hay C.W., Docherty K. Enhanced expression of a furin-cleavable proinsulin. J. Mol. Endocrinol. 2003, 31:597-607.
11. Henriksen O.M., Prahl J.B., Røder M.E., Svendsen O.L. Treatment of diabetic ketoacidosis in adults in Denmark: a national survey. Diabetes Res. Clin. Pract. 2007, 77:113-119.
12. Hovorka R. Closed-loop insulin delivery: from bench to clinical practice. Nat. Rev. Endocrinol. 2011, 7:385-395.
13. Ishii S., Kihara Y., Shimizu T. Identification of T cell death-associated gene 8 (TDAG8) as a novel acid sensing G-protein-coupled receptor. J. Biol. Chem. 2005, 280:9083-9087.
14. Jacobs-Tulleneers-Thevissen D., Chintinne M., Ling Z., Gillard P., Schoonjans L., Delvaux G., Strand B.L., Gorus F., Keymeulen B., Pipeleers D. Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient. Diabetologia 2013, 56:1605-1614. Beta Cell Therapy Consortium EU-FP7.
15. Kemmer C., Gitzinger M., Daoud-El Baba M., Djonov V., Stelling J., Fussenegger M. Self-sufficient control of urate homeostasis in mice by a synthetic circuit. Nat. Biotechnol. 2010, 28:355-360.
16. Khalil A.S., Collins J.J. Synthetic biology: applications come of age. Nat. Rev. Genet. 2010, 11:367-379.
17. Kitabchi A.E., Umpierrez G.E., Murphy M.B., Barrett E.J., Kreisberg R.A., Malone J.I., Wall B.M. Management of hyperglycemic crises in patients with diabetes. Diabetes Care 2001, 24:131-153.
18. Kitabchi A.E., Umpierrez G.E., Miles J.M., Fisher J.N. Hyperglycemic crises in adult patients with diabetes. Diabetes Care 2009, 32:1335-1343.
19. Kłapcińska B., Waśkiewicz Z., Chrapusta S.J., Sadowska-Krepa E., Czuba M., Langfort J. Metabolic responses to a 48-h ultra-marathon run in middle-aged male amateur runners. Eur. J. Appl. Physiol. 2013, 113:2781-2793.
20. Langhan M.L. Acute alcohol intoxication in adolescents: frequency of respiratory depression. J. Emerg. Med. 2013, 44:1063-1069.
21. Larsen J.L. Pancreas transplantation: indications and consequences. Endocr. Rev. 2004, 25:919-946.
22. Ludwig M.G., Vanek M., Guerini D., Gasser J.A., Jones C.E., Junker U., Hofstetter H., Wolf R.M., Seuwen K. Proton-sensing G-protein-coupled receptors. Nature 2003, 425:93-98.
23. Marguet P., Balagadde F., Tan C., You L. Biology by design: reduction and synthesis of cellular components and behaviour. J. R. Soc. Interface 2007, 4:607-623.
24. Nissim L., Bar-Ziv R.H. A tunable dual-promoter integrator for targeting of cancer cells. Mol. Syst. Biol. 2010, 6:444.
25. Pickup J.C. Management of diabetes mellitus: is the pump mightier than the pen?. Nat. Rev. Endocrinol. 2012, 8:425-433.
26. Pozzilli P. Type 1 diabetes mellitus in 2011: Heterogeneity of T1DM raises questions for therapy. Nat. Rev. Endocrinol. 2012, 8:78-80.
27. Raghunand N., Howison C., Sherry A.D., Zhang S., Gillies R.J. Renal and systemic pH imaging by contrast-enhanced MRI. Magn. Reson. Med. 2003, 49:249-257.
28. Randall L., Begovic J., Hudson M., Smiley D., Peng L., Pitre N., Umpierrez D., Umpierrez G. Recurrent diabetic ketoacidosis in inner-city minority patients: behavioral, socioeconomic, and psychosocial factors. Diabetes Care 2011, 34:1891-1896.
29. Rössger K., Charpin-El Hamri G., Fussenegger M. Reward-based hypertension control by a synthetic brain-dopamine interface. Proc. Natl. Acad. Sci. USA 2013, 110:18150-18155.
30. Rössger K., Charpin-El-Hamri G., Fussenegger M. A closed-loop synthetic gene circuit for the treatment of diet-induced obesity in mice. Nat Commun 2013, 4:2825.
31. Simonsen J.L., Rosada C., Serakinci N., Justesen J., Stenderup K., Rattan S.I., Jensen T.G., Kassem M. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat. Biotechnol. 2002, 20:592-596.
32. Stanley S.A., Gagner J.E., Damanpour S., Yoshida M., Dordick J.S., Friedman J.M. Radio-wave heating of iron oxide nanoparticles can regulate plasma glucose in mice. Science 2012, 336:604-608.
33. Tigges M., Marquez-Lago T.T., Stelling J., Fussenegger M. A tunable synthetic mammalian oscillator. Nature 2009, 457:309-312.
34. Tominaga M., Caterina M.J., Malmberg A.B., Rosen T.A., Gilbert H., Skinner K., Raumann B.E., Basbaum A.I., Julius D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998, 21:531-543.
35. Tresguerres M., Buck J., Levin L.R. Physiological carbon dioxide, bicarbonate, and pH sensing. Pflugers Arch. 2010, 460:953-964.
36. Van Cromphaut S.J., Vanhorebeek I., Van den Berghe G. Glucose metabolism and insulin resistance in sepsis. Curr. Pharm. Des. 2008, 14:1887-1899.
37. Waldmann R., Champigny G., Bassilana F., Heurteaux C., Lazdunski M. A proton-gated cation channel involved in acid-sensing. Nature 1997, 386:173-177.
38. Wang M.Y., Chen L., Clark G.O., Lee Y., Stevens R.D., Ilkayeva O.R., Wenner B.R., Bain J.R., Charron M.J., Newgard C.B., Unger R.H. Leptin therapy in insulin-deficient type I diabetes. Proc. Natl. Acad. Sci. USA 2010, 107:4813-4819.
39. Wasserman K., Cox T.A., Sietsema K.E. Ventilatory regulation of arterial H(+) (pH) during exercise. Respir. Physiol. Neurobiol. 2014, 190:142-148.
40. Weber W., Fussenegger M. Inducible product gene expression technology tailored to bioprocess engineering. Curr. Opin. Biotechnol. 2007, 18:399-410.
41. Weber W., Fussenegger M. Emerging biomedical applications of synthetic biology. Nat. Rev. Genet. 2012, 13:21-35.
42. Weber W., Rimann M., Spielmann M., Keller B., Daoud-El Baba M., Aubel D., Weber C.C., Fussenegger M. Gas-inducible transgene expression in mammalian cells and mice. Nat. Biotechnol. 2004, 22:1440-1444.
43. Weber W., Schoenmakers R., Keller B., Gitzinger M., Grau T., Daoud-El Baba M., Sander P., Fussenegger M. A synthetic mammalian gene circuit reveals antituberculosis compounds. Proc. Natl. Acad. Sci. USA 2008, 105:9994-9998.
44. Wieland M., Fussenegger M. Reprogrammed cell delivery for personalized medicine. Adv. Drug Deliv. Rev. 2012, 64:1477-1487.
45. Wiznerowicz M., Szulc J., Trono D. Tuning silence: conditional systems for RNA interference. Nat. Methods 2006, 3:682-688.
46. Wurm F.M. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat. Biotechnol. 2004, 22:1393-1398.
47. Ye H., Daoud-El Baba M., Peng R.W., Fussenegger M. A synthetic optogenetic transcription device enhances blood-glucose homeostasis in mice. Science 2011, 332:1565-1568.
48. Young E.W., Beebe D.J. Fundamentals of microfluidic cell culture in controlled microenvironments. Chem. Soc. Rev. 2010, 39:1036-1048.